您的位置: 首页 > 农业专利 > 详情页

Multiple-variable dose regimen for treating TNFalpha-related disorders
专利权人:
AbbVie Biotechnology Ltd
发明人:
Chartash, Elliot,Granneman,George Richard,Hoffman, Rebeca S.,Philip Yan,,Taylor, Lori K.
申请号:
AU2013204275
公开号:
AU2013204275B2
申请日:
2013.04.12
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
#$%^&*AU2013204275B220161222.pdf#####MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFa-RELATED DISORDERS Abstract Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNFinhibitor is administered in a higher dosage during the induction phase.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充